Platinum-resistance in ovarian cancer cells is mediated by IL-6 secretion via the increased expression of its target cIAP-2. (Q47563582)

4 February 2018

title

Platinum-resistance in ovarian cancer cells is mediated by IL-6 secretion via the increased expression of its target cIAP-2. (English)

1 reference

4 February 2018

1 reference

1 reference

Metsada Pasmanik-Chor

6

object named as

Metsada Pasmanik-Chor

1 reference

4 February 2018

Ilan Bruchim

2

object named as

Ilan Bruchim

1 reference

4 February 2018

author name string

Sharon Cohen

1

1 reference

4 February 2018

Dror Graiver

3

1 reference

4 February 2018

Zoharia Evron

4

1 reference

4 February 2018

Varda Oron-Karni

5

1 reference

4 February 2018

Ram Eitan

7

1 reference

4 February 2018

Joelle Bernheim

8

1 reference

4 February 2018

Hanoch Levavi

9

1 reference

4 February 2018

Ami Fishman

10

1 reference

4 February 2018

Eliezer Flescher

11

1 reference

4 February 2018

publication date

28 September 2012

1 reference

4 February 2018

Journal of Molecular Medicine

published in

1 reference

4 February 2018

volume

91

1 reference

4 February 2018

issue

3

1 reference

4 February 2018

page(s)

357-368

1 reference

4 February 2018

https://scigraph.springernature.com/pub.10.1007/s00109-012-0946-4

exact match

0 references

cites work

Epithelial ovarian cancer: prevention, diagnosis, and treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0946-4

The biology of ovarian cancer: new opportunities for translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0946-4

Protein interactions with platinum-DNA adducts: from structure to function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0946-4

Activation of NF-kappaB by antineoplastic agents. Role of protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0946-4

Taxane-mediated gene induction is independent of microtubule stabilization: induction of transcription regulators and enzymes that modulate inflammation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0946-4

Methyl jasmonate: a plant stress hormone as an anti-cancer drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0946-4

Broadening the clinical use of platinum drug-based chemotherapy with new analogues. Satraplatin and picoplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0946-4

Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0946-4

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0946-4

Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0946-4

Aurora kinases: new targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0946-4

Overexpression of the centrosomal protein Aurora-A kinase is associated with poor prognosis in epithelial ovarian cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0946-4

Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0946-4

Cytokines and their relationship to the symptoms and outcome of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0946-4

A genetically defined model for human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0946-4

Long-term platinum retention after treatment with cisplatin and oxaliplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0946-4

Regulation of growth of prostate cancer cells selected in the presence of interleukin-6 by the anti-interleukin-6 antibody CNTO 328.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0946-4

Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0946-4

Nuclear factor-kappaB in cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0946-4

IL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching/effacing lesion-forming enteric bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0946-4

Anti-interleukin-6 monoclonal antibody induces regression of human prostate cancer xenografts in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0946-4

Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0946-4

The inhibitors of apoptosis (IAPs) as cancer targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0946-4

IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0946-4

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0946-4

Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines.

21 January 2018

1 reference

12 December 2020

Mitogen-activated protein kinases (MAPK) as predictors of clinical outcome in serous ovarian carcinoma in effusions

1 reference

12 December 2020

Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin

1 reference

12 December 2020

Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence.

1 reference

12 December 2020

Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody.

1 reference

12 December 2020

Clinical evaluation of tocilizumab for patients with active rheumatoid arthritis refractory to anti-TNF biologics: tocilizumab in combination with methotrexate

1 reference

12 December 2020

A clinical study assessing the tolerability and biological effects of infliximab, a TNF-α inhibitor, in patients with advanced cancer

1 reference

12 December 2020

Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines.

1 reference

12 December 2020

Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway

1 reference

12 December 2020

Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer

1 reference

12 December 2020

Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: analysis of interleukin (IL) 6, IL-8, and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype.

1 reference

12 December 2020

Immunocytochemical detection of XIAP in body cavity effusions and washes

1 reference

12 December 2020

The anti-tumour agent, cisplatin, and its clinically ineffective isomer, transplatin, produce unique gene expression profiles in human cells

1 reference

12 December 2020

Alteration and clinical relevance of PTEN expression and its correlation with survivin expression in epithelial ovarian tumors.

1 reference

12 December 2020

10.1007/S00109-012-0946-4

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018